• Share:

Funding

NIH Funding:

Targeted Therapies in Melanoma
PI: Meenhard Herlyn
Type: P01
May 2008 – April 2013
Sub-project on grant:  Targeting the MAP and P13 Kinase pathways in melanoma

Human Melanoma – Etiology, Progression and Therapy
PI: Meenhard Herlyn
Type: P01
April 2011 – March 2016
Sub-project on grant: Cellular mechanisms of therapy resistance in melanoma

3D Human Skin Models
PI: Meenhard Herlyn
Type: R01
September 2009 – July 2012

Biology of Melanoma Metastasis
PI: Meenhard Herlyn
Type: R01
January 2011 – December 2015

Cell-cell communication during melanoma development
PI: Meenhard Herlyn
Type: R01
April 2011 – March 2016

Mechanisms of Esophageal Carcinogenesis
PI: Anil Rusgti
Type: P01
July 2009 – June 2014
Sub-project on grant: Targeting signaling pathways in esophageal carcinoma

 

Non-NIH Funding:

Adelson Medical Research Foundation
Therapeutic Targeting of drug resistant melanomas
August 2010 – July 2012

Melanoma Research Foundation
Preclinical Studies within the MRF-BC
January-December 2012

Noreen O'Neill Foundation for Melanoma Research
Melanoma Research grant
August 2012 - July 2013